21054 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors from animals; from humans
Compositions and methods for prevention of photoaging
#902Protease for activating clotting factor VII
#903Modified adenoviral vectors for use in vaccines and gene therapy
#904Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
#905Mucoadhesive drug delivery devices and methods of making and using thereof
#906Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants
#907Metalloproteinase inhibitory agent
#908Method for using lipoprotein associated coagulation inhibitor to treat sepsis
#909Use of aerosolized antithrombin to treat acute lung injury
#910Kallikrein-inhibitor therapies
#911Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
#912Cysteine protease inhibitor
#913Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
#914Inhibition of invasive remodelling
#915Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
#916Anti-angiogenic compositions and methods of use
#917Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
#918Drugs ameliorating hypo-hdl cholesterolemia
#919Biologically stable liquid composition of FVIII, of vWF or of FVIII/vWF complex of human origin
#920Compositions for treatment and prevention of pulmonary conditions
#921Compositions capable of facilitating penetration across a biological barrier
#922Medicament against thrombotic diseases
#923Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof
#924Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
#925Broad spectrum anti-viral therapeutics and prophylaxis
#926Pharmaceutical combination therapy and prevention with aprotinin + nirmatrelvir of SARS-CoV-2 and/or disease associated with this infection, including COVID-19
#927Processes for making and using a mesenchymal stem cell derived secretome